Pharmaceuticals, Biotechnology and Life Sciences
Online event will examine the growth of U.S. cannabis market, the role of leading cannabis companies, legal challenges, and other…
Initial safety data showed combination regimen at the recommended Phase 2 dose was well tolerated; treatment-related adverse events primarily Grade…
First proof-of-concept in vivo data for RNA editing using endogenous ADAR enzymes in alpha-1 antitrypsin deficiency ADAR editing resulted in…
– Co-founder Romesh Subramanian, Ph.D., stepping down as chief scientific officer and will serve as an advisor after leading successful…
Studies support potentially important anti-inflammatory, protein modulation, and cell function effects of icosapent ethyl as known by the brand name…
SAN FRANCISCO, June 02, 2021 (GLOBE NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that George Scangos, Ph.D., chief…
SEATTLE, June 02, 2021 (GLOBE NEWSWIRE) — Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered…
SAN DIEGO and TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX:…
Approval for moderate to severe pediatric patients six years and older is based on pivotal trial data showing Cosentyx demonstrated…
ROLLING MEADOWS, Ill., June 01, 2021 (GLOBE NEWSWIRE) — Cambium Networks Corporation (Nasdaq: CMBM) (“Cambium”), a leading global provider of…